“As you know I think tight control is a good idea. The clinical study that is going to prove that tight control prevents vascular disease is about halfway done and is looking promising. So let’s stick with your tight control. I don’t want your kidneys to fail.” This was the first I heard of the DCCT study, from Dr. Andrew Drexler, when I lived in New York City and was his patient.
-
Scott King is the President of Cerco Medical, a biotechnology company working with the Hanuman Medical Foundation to develop the Islet Sheet, a solution to diabetes. He was diagnosed with type 1 diabetes in 1977, and since then has been devoted to understanding and curing the disease. The Hanuman Medical Foundation is pleased to present his occasional essays on what he has learned over the years of studying this personal disease.
-
You are currently browsing the The Solving Diabetes Project blog archives for December, 2009.
Recent Essays
Categories
- Current Research (9)
- Guest Essays (2)
- Scott's Opinion (14)
- The Marat/King Dialogues (8)
- Type 1 Diabetes Classic (3)
Authors
- Dr. Andrew Drexler (1)
- J P Marat (8)
- Randy Dorian (1)
- Scott King (26)
-
Recent Comments
Archives